scispace - formally typeset
C

Christelle Laguillier

Researcher at University of Paris

Publications -  18
Citations -  698

Christelle Laguillier is an academic researcher from University of Paris. The author has contributed to research in topics: Chemokine & Alcoholic liver disease. The author has an hindex of 12, co-authored 16 publications receiving 630 citations. Previous affiliations of Christelle Laguillier include French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis

TL;DR: This study provides key data that affirm the influence of the rs738409 (GG) genotype on the occurrence of HCC in patients with alcoholic cirrhosis and refines the selection of patients at higher risk of liver cancer development.
Journal ArticleDOI

RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans

TL;DR: It is demonstrated that chemokine oligomerization and binding to GAGs are essential in RANTES/CCL5-induced angiogenic effects and new therapeutic strategies can be proposed for neo-angiogenesis after vascular injury.
Journal ArticleDOI

Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.

TL;DR: The combination of the GG‐MPO genotype (leading to high MPO expression) and at least one Ala‐SOD2 allele (associated with high liver iron score) markedly increased the risks of HCC occurrence and death in patients with alcoholic cirrhosis.
Journal ArticleDOI

Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.

TL;DR: The data show that human liver myofibroblasts act on hepatoma cells in a paracrine manner to increase their invasiveness and suggest that my ofibroblast‐derived MCP‐1/CCL2 could be involved in the pathogenesis of hepatocellular carcinoma.